NeoVax Vaccine and Nivolumab Show Promise on Safety in Early StudyBy Ronan FitzgeraldOctober 16, 2026 A phase 1 trial of the personalised NeoVax vaccine with nivolumab in ovarian cancer found the approach feasible with acceptable safety. Here is what it means.